216 related articles for article (PubMed ID: 38335292)
1. Stromal-derived MAOB promotes prostate cancer growth and progression.
Pu T; Wang J; Wei J; Zeng A; Zhang J; Chen J; Yin L; Li J; Lin TP; Melamed J; Corey E; Gao AC; Wu BJ
Sci Adv; 2024 Feb; 10(6):eadi4935. PubMed ID: 38335292
[TBL] [Abstract][Full Text] [Related]
2. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
Li J; Pu T; Yin L; Li Q; Liao CP; Wu BJ
Oncogene; 2020 Apr; 39(16):3305-3321. PubMed ID: 32066880
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
[TBL] [Abstract][Full Text] [Related]
4. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.
Yin L; Li J; Wang J; Pu T; Wei J; Li Q; Wu BJ
Oncogene; 2021 Feb; 40(7):1362-1374. PubMed ID: 33420365
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.
Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW
J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth.
Quach ND; Kaur SP; Eggert MW; Ingram L; Ghosh D; Sheth S; Nagy T; Dawson MR; Arnold RD; Cummings BS
Sci Rep; 2019 Aug; 9(1):11478. PubMed ID: 31391540
[TBL] [Abstract][Full Text] [Related]
8. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
[TBL] [Abstract][Full Text] [Related]
11. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
13. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
14. MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the disease.
Huang HC; Hsieh YH; Hsiao CH; Lin CY; Wang SS; Ho KH; Chang LC; Huang HM; Yang SF; Chien MH
J Cell Mol Med; 2024 Apr; 28(8):e18229. PubMed ID: 38520217
[TBL] [Abstract][Full Text] [Related]
15. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
16. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.
Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR
Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060
[TBL] [Abstract][Full Text] [Related]
17. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
Dakhova O; Rowley D; Ittmann M
Clin Cancer Res; 2014 Jan; 20(1):100-9. PubMed ID: 24150235
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men.
Gillard M; Javier R; Ji Y; Zheng SL; Xu J; Brendler CB; Crawford SE; Pierce BL; Griend DJV; Franco OE
Cancer Res; 2018 Nov; 78(21):6134-6145. PubMed ID: 30181178
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells.
Huang M; Narita S; Koizumi A; Nara T; Numakura K; Satoh S; Nanjo H; Habuchi T
Cancer Commun (Lond); 2021 May; 41(5):389-403. PubMed ID: 33773090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]